Latest News

In 2020, more than 1.5 million people died of tuberculosis (TB). Now, researchers have developed a TB drug that showed potential with just one injection that lasts at least four months, improving on current treatment which requires daily medication.

Researchers have developed a powerful immunity-boosting postoperative hydrogel treatment that could improve the outlook for patients with glioblastoma.

Scientists at the University of California, Berkeley, have created a new COVID-19 therapeutic that could one day make treating SARS-CoV-2 infections as easy as using a nasal spray for allergies.

New research suggests that people with elevated levels of the protein prostasin, which is mainly found in epithelial cells which line the surfaces and organs of the body, may be at higher risk of developing diabetes or dying from cancer.

The immune boosting benefits of a tuberculosis vaccine can be seen in infants more than one year after vaccination, according to a new study.

Researchers have produced a method to turn carbenes, short-lived, high-energy molecules, into much more stable ones for the synthesis of new drugs.

Researchers have developed a novel drug called αAβ-Gas6 which efficiently eliminates amyloid beta – which causes Alzheimer's disease – while avoiding inflammatory side effects associated with conventional antibody treatments.

A new method of producing antibiotics by modifying existing natural products by adding fluorine has been developed, opening doors for the discovery of new therapeutics.

Researchers have now developed a special hydrogel that vastly improves the shelf life of vaccines, even without refrigeration.

A new study from researchers at the University of Sydney has explored how 10 different diets – including those high in protein, carbohydrates and fat – affect the gut microbiota in mice.